Works matching IS 01676997 AND DT 2011 AND VI 29 AND IP 1

Results: 25

Eugenol inhibits cell proliferation via NF-[kappa]B suppression in a rat model of gastric carcinogenesis induced by MNNG.

Published in:

2011

By:

Manikandan, P.;
Vinothini, G.;
Priyadarsini, Vidya;
Prathiba, D.;
Nagini, S.

Publication type:

Journal Article

Structure-activity relationships between the Aconitum C20-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkin's lymphoma Raji cells and human hematopoietic stem/progenitor cells.

Published in:

2011

By:

Hazawa, Masaharu;
Takahashi, Kenji;
Wada, Koji;
Mori, Takao;
Kawahara, Norio;
Kashiwakura, Ikua

Publication type:

Journal Article

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 126, doi. 10.1007/s10637-009-9322-9

By:

Nock, Charles;
Brell, Joanna;
Bokar, Joseph;
Cooney, Matthew;
Cooper, Brenda;
Gibbons, Joseph;
Krishnamurthi, Smitha;
Manda, Sudhir;
Savvides, Panayiotis;
Remick, Scot;
Ivy, Percy;
Dowlati, Afshin

Publication type:

Article

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 144, doi. 10.1007/s10637-009-9307-8

By:

Richards, Donald;
Kuefler, Paul;
Becerra, Carlos;
Wilfong, Lalan;
Gersh, Robert;
Boehm, Kristi;
Zhan, Feng;
Asmar, Lina;
Myrand, Scott;
Hozak, Rebecca;
Zhao, Luping;
Gill, John;
Mullaney, Brian;
Obasaju, Coleman;
Nicol, Steven

Publication type:

Article

Role of Neridronate on MCF-7 estrogen dependent breast cancer model of bone metastasis: a preliminary study.

Published in:

2011

By:

Nicolin, Vanessa;
Narducci, Paola;
Bareggi, Renato

Publication type:

Report

Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 22, doi. 10.1007/s10637-009-9329-2

By:

Balandin, Taras;
Edelweiss, Evelina;
Andronova, Natalia;
Treshalina, Elena;
Sapozhnikov, Alexander;
Deyev, Sergey

Publication type:

Article

Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 9, doi. 10.1007/s10637-009-9328-3

By:

Kruczynski, Anna;
Vandenberghe, Isabelle;
Pillon, Arnaud;
Pesnel, Sabrina;
Goetsch, Liliane;
Barret, Jean-Marc;
Guminski, Yves;
Pape, Alain;
Imbert, Thierry;
Bailly, Christian;
Guilbaud, Nicolas

Publication type:

Article

A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 167, doi. 10.1007/s10637-009-9341-6

By:

Wierzbicki, Rafal;
Jonker, Derek;
Moore, Malcolm;
Berry, Scott;
Loehrer, Patrick;
Youssoufian, Hagop;
Rowinsky, Eric

Publication type:

Article

TNF-blockade in patients with advanced hormone refractory prostate cancer.

Published in:

2011

By:

Diaz, Luis;
Messersmith, Wells;
Sokoll, Lori;
Sinibaldi, Vicki;
Moore, Sandy;
Carducci, Michael;
Eisenberger, Mario

Publication type:

Report

Efficacy of Caffeic Acid Phenethyl Ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 52, doi. 10.1007/s10637-009-9334-5

By:

Kudugunti, Shashi;
Vad, Nikhil;
Ekogbo, Ehi;
Moridani, Majid

Publication type:

Article

Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 110, doi. 10.1007/s10637-009-9345-2

By:

Manikandan, P.;
Vinothini, G.;
Vidya Priyadarsini, R.;
Prathiba, D.;
Nagini, S.

Publication type:

Article

Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 41, doi. 10.1007/s10637-009-9331-8

By:

Colon, Jimmie;
Basha, Md.;
Madero-Visbal, Rafael;
Konduri, Santhi;
Baker, Cheryl;
Herrera, Luis;
Safe, Stephen;
Sheikh-Hamad, David;
Abudayyeh, Ala;
Alvarado, Beatrice;
Abdelrahim, Maen

Publication type:

Article

A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 63, doi. 10.1007/s10637-009-9335-4

By:

Singh, Rakesh;
Lange, Thilo;
Kim, Kyu;
Brard, Laurent

Publication type:

Article

Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 98, doi. 10.1007/s10637-009-9340-7

By:

Viale, Maurizio;
Cordazzo, Cinzia;
Totero, Daniela;
Budriesi, Roberta;
Rosano, Camillo;
Leoni, Alberto;
Ioan, Pierfranco;
Aiello, Cinzia;
Croce, Michela;
Andreani, Aldo;
Rambaldi, Mirella;
Russo, Patrizia;
Chiarini, Alberto;
Spinelli, Domenico

Publication type:

Article

Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 175, doi. 10.1007/s10637-009-9343-4

By:

Jo, Jae-Cheol;
Kang, Byung;
Sym, Sun;
Lee, Sung;
Jang, Geundoo;
Kim, Shin;
Lee, Dae;
Kim, Sang-We;
Lee, Jung;
Suh, Cheolwon

Publication type:

Article

A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 161, doi. 10.1007/s10637-009-9333-6

By:

Lewis, Karl;
Samlowski, Wolfram;
Ward, John;
Catlett, Joseph;
Cranmer, Lee;
Kirkwood, John;
Lawson, David;
Whitman, Eric;
Gonzalez, Rene

Publication type:

Article

Phase I trial of vinflunine and pemetrexed in refractory solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 131, doi. 10.1007/s10637-009-9344-3

By:

Sanoff, Hanna;
Davies, Janine;
Walko, Christine;
Buie, Larry;
Chiu, Wing-Keung;
Ivanova, Anastasia;
O'Neil, Bert;
Stinchcombe, Thomas;
Keller, Kimberly;
Dees, E.

Publication type:

Article

Structure-activity relationships between the Aconitum C-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkin's lymphoma Raji cells and human hematopoietic stem/progenitor cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 1, doi. 10.1007/s10637-009-9327-4

By:

Hazawa, Masaharu;
Takahashi, Kenji;
Wada, Koji;
Mori, Takao;
Kawahara, Norio;
Kashiwakura, Ikuo

Publication type:

Article

PKC-alpha inhibitor MT477 slows tumor growth with minimal toxicity in in vivo model of non-Ras-mutated cancer via induction of apoptosis.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 33, doi. 10.1007/s10637-009-9330-9

By:

Jasinski, Piotr;
Zwolak, Pawel;
Terai, Kaoru;
Borja-Cacho, Daniel;
Dudek, Arkadiusz

Publication type:

Article

Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 87, doi. 10.1007/s10637-009-9339-0

By:

Somers-Edgar, Tiffany;
Taurin, Sebastien;
Larsen, Lesley;
Chandramouli, Anupama;
Nelson, Mark;
Rosengren, Rhonda

Publication type:

Article

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 137, doi. 10.1007/s10637-009-9347-0

By:

Steeghs, Neeltje;
Gelderblom, Hans;
Wessels, Judith;
Eskens, Ferry;
Bont, Natasja;
Nortier, Johan;
Guchelaar, Henk-Jan

Publication type:

Article

Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and-resistant human ovarian cancer cells.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 73, doi. 10.1007/s10637-009-9336-3

By:

Marverti, Gaetano;
Ligabue, Alessio;
Montanari, Monica;
Guerrieri, Davide;
Cusumano, Matteo;
Pietro, Maria;
Troiano, Leonarda;
Vono, Elena;
Iotti, Stefano;
Farruggia, Giovanna;
Wolf, Federica;
Monti, Maria;
Frassineti, Chiara

Publication type:

Article

Bevacizumab for salvage treatment of metastatic breast cancer: a systemic review and meta-analysis of randomized controlled trials.

Published in:

2011

By:

Lee, Jae-Bok;
Woo, Ok;
Park, Kyong;
Woo, Sang;
Yang, Dae;
Kim, Ae-Ree;
Lee, Eun;
Kim, Yeul;
Kim, Jun;
Seo, Jae

Publication type:

Report

Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 154, doi. 10.1007/s10637-009-9320-y

By:

Park, Byeong-Bae;
Kim, Won;
Eom, Hyeon;
Kim, Jin;
Lee, Young;
Oh, Suk;
Lee, Dae;
Suh, Cheolwon

Publication type:

Article

A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 118, doi. 10.1007/s10637-009-9318-5

By:

Schelman, William;
Liu, Glenn;
Wilding, George;
Morris, Thomas;
Phung, De;
Dreicer, Robert

Publication type:

Article